Neuropathy and IgM M-proteins: Prognostic value of antibodies to MAG, SGPG, and sulfatide

Neurology

Volumn 56, Issue 2, 2001, Pages 228-233

  Eurelings, M ^a   Moons, K G M ^b   Notermans, N C ^a   Sasker, L D ^a   De Jager, A E J ^c   Wintzen, A R ^d   Wokke, J H J ^a   Van Den Berg, L H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN M; M PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN ANTIBODY; SULFATIDE ANTIBODY; SULFOGLUCURONYL PARAGLOBOSIDE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHRONOLOGY; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMYELINATION; DISABILITY; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; GAMMOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; POLYNEUROPATHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035936620     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.2.228     Document Type: Article

References (46)

1. Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects
2. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
3. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
4. Neuropathies associated with monoclonal gammopathies
5. Laboratory testing in peripheral nerve disease
6. Anti-MAG and anti-SGPG antibodies in neuropathy
7. Neuropathies associated with paraproteinemia
8. Autoantibodies associated with peripheral neuropathy
9. Paraproteinaemic neuropathies
10. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein
11. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein
12. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases
13. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy
14. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening
15. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy
16. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy
17. Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal gammopathy and polyneuropathy
18. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide
19. Antisulfatide antibodies in neuropathy: Clinical and electrophysiologic correlates
20. Autopsy-proven amyotrophic lateral sclerosis, Waldenstrom's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside
21. Antiglycolipid antibodies in motor neuropatkies
22. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein
23. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy
24. Antisulphatide antibodies in peripheral neuropathy
25. Polyneurepathies associated with high titre antisulphatide antibodies: Characteristics of patients with and without serum monoclonal proteins
26. Neuropathy associated with monoclonal gammopathies of undetermined significance
27. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: Further evidence that IgM-MGUS neuropathies are different than IgG-MGUS
28. Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases
29. Chronic idiopathic polyneuropathy presenting in middle or old age: A clinical and electrophysiological study of 75 patients
30. Interobserver agreement for assessment of handicap in stroke patients
31. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy
32. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force
33. Multifocal motor neuropathy with conduction block: Is it a distinct entity?
34. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance
35. Neuropathy and anti-MAG antibodies without detectable serum M-protein
36. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia
37. A new procedure for the extraction, purification and fractionation of brain gangliosides
38. The neuropathy of plasma cell dyscrasia: Binding of IgM M-proteins to peripheral nerve glycolipids
39. Polyneuropathy and IgM monoclonal gammopathy: Studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody
40. Polyneuropathies associated with IgM monoclonal gammopathies
41. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group
42. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group
43. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy
44. Anti-MAG antibodies: Major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation
45. Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody